![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[Powder data file]](/e/graphics/powderdataborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Issue contents]](/e/graphics/issuecontentsborder.gif)
![[Open access]](/e/graphics/free.gif)
![[Contents scheme]](cv6560contents.gif)
Acta Cryst. (2005). E61, o2974-o2977 [ doi:10.1107/S1600536805025651 ]
Abstract: A polycrystalline sample of the title compound, C7H8ClN3O4S2·C3H6O2, was produced during an automated parallel crystallization search on hydrochlorothiazide (HCT). The crystal structure was solved by simulated annealing from laboratory X-ray powder diffraction data collected at room temperature to 1.75 Å resolution. Subsequent Rietveld refinement yielded an Rwp value of 0.0182 to 1.54 Å resolution. The compound crystallizes with one molecule of HCT and one of methyl acetate in the asymmetric unit and displays an extensive hydrogen-bonding network.
Online 17 August 2005
Copyright © International Union of Crystallography
IUCr Webmaster